Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
Biotech
STAT+
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Health Tech
STAT+

Why Amazon and other corporate giants are in a bidding war for home health technology

  • Casey Ross
  • Katie Palmer

By Casey Ross and Katie Palmer Aug. 25, 2022

Reprints
Adobe

Update: On Sept. 5, CVS Health cemented its move into home care, announcing an agreement to buy Signify Health for a total value of about $8 billion.

The bidding war over Signify Health — a health technology business that could fetch multibillion-dollar offers from Amazon, CVS, and UnitedHealth Group — is not about its dazzling software or a blockbuster AI algorithm.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Authors Reprints

Casey Ross

Casey Ross

National Technology Correspondent

Casey covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy.

Katie Palmer

Katie Palmer

Health Tech Correspondent

Katie is a health tech correspondent at STAT.

Tags

Create a display name to comment

This name will appear with your comment

New study sees possible link between aluminum in childhood…
New study sees possible link between aluminum in childhood vaccines and risk of asthma, but caveats…
Surgeons often take a fifth of the lungs to…
Surgeons often take a fifth of the lungs to remove a small tumor. There may be…
Push to double up on Covid booster and flu…
Push to double up on Covid booster and flu shot may have a downside, experts caution
Pharmalittle: Medicare plans sizable infrastructure for negotiating drug prices;…
Pharmalittle: Medicare plans sizable infrastructure for negotiating drug prices; Alzheimer’s data also boost Roche and Lilly
Medicare lays out the bureaucracy it will need to…
Medicare lays out the bureaucracy it will need to negotiate drug prices
Burning questions left unanswered about the latest Alzheimer’s therapy
Burning questions left unanswered about the latest Alzheimer’s therapy

Recommended Stories